Verrica confirms separation agreements with former CCO Joe Bonaccorso

Verrica Pharmaceuticals Inc.

On August 30, 2024, Verrica entered into Release and Consulting Agreements with former CCO Joe Bonaccorso.
Terms of the agreements were disclosed on August 27, 2024 and remain unchanged.
The agreements formalize Bonaccorso's departure as Chief Commercial Officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joe Bonaccorso

Chief Commercial Officer

VRCA · Verrica Pharmaceuticals Inc.

Effective: 2024-08-30
Filed: September 6, 2024, 7:59 PM ET

on August 30, 2024, the Company and Joe Bonaccorso, the Company’s former Chief Commercial Officer, entered into a Release Agreement and a Consulting Agreement

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joe Bonaccorso departed as Chief Commercial Officer at Verrica Pharmaceuticals Inc..

Action: departed
Role: Chief Commercial Officer

Exact text from the filing

on August 30, 2024, the Company and Joe Bonaccorso, the Company’s former Chief Commercial Officer, entered into a Release Agreement and a Consulting Agreement

View on SEC.gov

Verrica Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-215180

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.